Sabinsa has opened an office in the greater Toronto area, expanding the company’s already significant presence in the Canadian dietary supplements market.
Sabinsa currently has 30 Natural Product Numbers (NPN) approved by Health Canada. Curcumin C3 Complex®, Curcumin C3 Reduct®, LactoSpore®, BioPerine®, and ForsLean® are among Sabinsa’s research-backed branded ingredients available for Letter of Access requests.
This new office and any customers in Canada can also coordinate contract manufacturing services from Sabinsa’s Utah Contract Manufacturing facility, which has a registered Foreign Site Reference Number (FSRN), a service offered by Health Canada to permit Canadian importers to more efficiently demonstrate compliance with various regulations for Canada.
“This expansion is part of our growth strategy in Canada for our ingredients and services,” said Sabinsa founder Dr. Muhammed Majeed. “Our next step is to open a warehouse in the area, which will reduce the transit time and logistical hurdles to get the orders to customers more quickly.”
“The Canadian supplement industry has been growing at a robust pace; Sabinsa wanted to contribute to this growth by facilitating access to our ingredients by Canadian companies and its end consumers,” added Shaheen Majeed, President Worldwide, Sabinsa. “The office will help serve our Canadian customers with information on health claims approved by the Canadian Health Directorate (NHPD).”
Nida Saleem, Sales and Marketing Executive, is managing Sabinsa Canada operations.
Toronto Airport Corporate Centre
2425 Matheson Blvd E, Ste 800
Mississauga, ON L4W 5K4, Canada
Office: +1 (905) 361-6828